Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Shares of Arena Pharmaceutical (ARNA +1.8%) and Vivus (VVUS +3.3%) both gain today, after...

  • Wednesday, February 6, 12:20 PM ET
    Shares of Arena Pharmaceutical (ARNA +1.8%) and Vivus (VVUS +3.3%) both gain today, after Leerink Swann resumes coverage on both with an Outperform rating. The firm gives VVUS a price target range of $19 - $20.
Track new comments on this story

This news story has 2 comments:

  • Leerink Swann reports from DREAMLAND that VIVUS will rise 30% plus from $13.45 to $20.00. If one wants a 30% rise your chances are much better buying ARNA !!!!!!!!!!!!!
    6 Feb, 04:38 PM Reply Like
  • Yeah, the general public stopped paying attention to Areniacs after approval didn't get you to $15-$20 like you all foretold. Real money is following Vivus again as they're getting stronger and building steam leading up to announcements regarding Stendra partnerships etc.

    Can't wait for the EMA's decision on Belviq. I hope it'll shut some of you guys up a bit, but I know you'll just cling to a new fallacy.
    6 Feb, 10:30 PM Reply Like
Other date
DJIA (DIA) S&P 500 (SPY)